Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1IH0

Structure of the C-domain of Human Cardiac Troponin C in Complex with Ca2+ Sensitizer EMD 57033

Summary for 1IH0
Entry DOI10.2210/pdb1ih0/pdb
Related1AJ4
NMR InformationBMRB: 4994
DescriptorTROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES, CALCIUM ION, 5-[1-(3,4-DIMETHOXY-BENZOYL)-1,2,3,4-TETRAHYDRO-QUINOLIN-6-YL]-6-METHYL-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-ONE (3 entities in total)
Functional Keywordsca2+ binding protein, ca2+ sensitizer, contractile protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight8757.69
Authors
Wang, X.,Li, M.X.,Spyracopoulos, L.,Beier, N.,Chandra, M.,Solaro, R.J.,Sykes, B.D. (deposition date: 2001-04-18, release date: 2001-10-10, Last modification date: 2024-05-22)
Primary citationWang, X.,Li, M.X.,Spyracopoulos, L.,Beier, N.,Chandra, M.,Solaro, R.J.,Sykes, B.D.
Structure of the C-domain of human cardiac troponin C in complex with the Ca2+ sensitizing drug EMD 57033.
J.Biol.Chem., 276:25456-25466, 2001
Cited by
PubMed Abstract: Ca(2+) binding to cardiac troponin C (cTnC) triggers contraction in heart muscle. In heart failure, myofilaments response to Ca(2+) are often altered and compounds that sensitize the myofilaments to Ca(2+) possess therapeutic value in this syndrome. One of the most potent and selective Ca(2+) sensitizers is the thiadiazinone derivative EMD 57033, which increases myocardial contractile function both in vivo and in vitro and interacts with cTnC in vitro. We have determined the NMR structure of the 1:1 complex between Ca(2+)-saturated C-domain of human cTnC (cCTnC) and EMD 57033. Favorable hydrophobic interactions between the drug and the protein position EMD 57033 in the hydrophobic cleft of the protein. The drug molecule is orientated such that the chiral group of EMD 57033 fits deep in the hydrophobic pocket and makes several key contacts with the protein. This stereospecific interaction explains why the (-)-enantiomer of EMD 57033 is inactive. Titrations of the cCTnC.EMD 57033 complex with two regions of cardiac troponin I (cTnI(34-71) and cTnI(128-147)) reveal that the drug does not share a common binding epitope with cTnI(128-147) but is completely displaced by cTnI(34-71). These results have important implications for elucidating the mechanism of the Ca(2+) sensitizing effect of EMD 57033 in cardiac muscle contraction.
PubMed: 11320096
DOI: 10.1074/jbc.M102418200
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon